Laura Cardeñoso
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 3
- HIV/AIDS drug development and treatment 3
- Virology top 10%
- HIV Research and Treatment 3
- Epidemiology top 10%
- Cytomegalovirus and herpesvirus research 9
- Herpesvirus Infections and Treatments 8
-
- Antibiotic Resistance in Bacteria 4
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- Bryan CobbHans H. HirschBenjamin A. PinskyIrmeli LautenschlagerShagufta AslamRegis A. VilchezAlexandra ValsamakisClara Aguirre
- Journals
- Multiple Sclerosis and Related Disorders (2 papers)Journal of Medical Virology (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)
- Partner nations
- SpainSwitzerlandFinland
In The Last Decade
Laura Cardeñoso
26 papers receiving 405 citations
Peers
Comparison fields: 5 of 60
- Infectious Diseases 176
- Virology 44
- Epidemiology 256
- Transplantation 12
- Hepatology 33
Countries citing papers authored by Laura Cardeñoso
This map shows the geographic impact of Laura Cardeñoso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Cardeñoso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Cardeñoso more than expected).
Fields of papers citing papers by Laura Cardeñoso
This network shows the impact of papers produced by Laura Cardeñoso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Cardeñoso. The network helps show where Laura Cardeñoso may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laura Cardeñoso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 5 | |
| 4 | 2021 | 17 | |
| 5 | 2021 | 7 | |
| 6 | 2020 | 40 | |
| 7 | 2020 | 7 | |
| 8 | 2020 | 18 | |
| 9 | 2020 | 20 | |
| 10 | 2020 | 1 | |
| 11 | 2020 | 3 | |
| 12 | 2019 | 8 | |
| 13 | 2019 | 4 | |
| 14 | 2016 | 9 | |
| 15 | 2016 | 29 | |
| 16 | 2012 | 95 | |
| 17 | 2012 | 20 | |
| 18 | 2009 | 30 | |
| 19 | 2001 | 14 | |
| 20 | 1998 | 11 |
About Laura Cardeñoso
Laura Cardeñoso is a scholar working on Molecular Medicine, Virology and Infectious Diseases, having authored 26 papers that have together received 415 indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (9 papers), Herpesvirus Infections and Treatments (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Antibiotic Resistance in Bacteria (4 papers), HIV Research and Treatment (3 papers), COVID-19 Clinical Research Studies (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Infectious Diseases (176 citations), Virology (44 citations) and Epidemiology (256 citations). Laura Cardeñoso has collaborated with scholars based in Spain, Switzerland and Finland. Frequent co-authors include Bryan Cobb, Hans H. Hirsch, Benjamin A. Pinsky, Irmeli Lautenschlager, Shagufta Aslam, Regis A. Vilchez, Alexandra Valsamakis, Clara Aguirre, José Vivancos and Virginia Meca‐Lallana. Their work appears in journals such as Multiple Sclerosis and Related Disorders, Journal of Medical Virology, European Journal of Clinical Microbiology & Infectious Diseases, Scientific Reports and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.